
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is expected to see continued growth in the future due to their new product, successful Q2 results, and strong performance in their Nutrition and Diagnostics segments. With a focus on high-growth areas and a diverse workforce, the company has a positive outlook for top-line and EPS growth. As a result, this stock is recommended as an overweight investment.
Bears say
Abbott Laboratories is facing potential risks with healthcare policies, competition, and tariffs, which could lead to multiple contractions, impacting the company's financial performance. While the company has a strong Medical Device product portfolio, robust cash generation, and a strong pipeline of new products, there are uncertainties surrounding healthcare policies and regulations that could negatively impact the company's growth. Additionally, the company may face challenges in commercial execution and competition, potentially leading to a decline in sales and profitability.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares